Tofacitinib for cutaneous and pulmonary sarcoidosis: a case series

Published: 06-08-2020| Version 1 | DOI: 10.17632/626cszwvm2.1
Contributor:
Karolina Kerkemeyer

Description

Figure 1. 63-year-old patient with severe photo-aggravated cutaneous sarcoidosis at baseline and after 2 months of treatment with oral tofacitinib showing reduction in erythema, induration and extent of skin involvement.

Files